Non disponible en dehors du Royaume-Uni et de l'Irlande
Application
Lenalidomide is a ligand demonstrated to bind the Cereblon (CRBN) protein. Lenalidomide, along with other thalidomide derivatives, are useful for constructing small molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. Explore protein degrader building blocks, E3 ligase ligand-linker conjugates that simplify the synthesis and library generation of PROTACs..
Legal Information
PROTAC is a registered trademark of Arvinas Operations, Inc., and is used under license
Other Notes
Technology Spotlight: Degrader Building Blocks for Targeted Protein DegradationPortal: Building PROTAC® Degraders for Targeted Protein DegradationStructure of the human Cereblon–DDB1–lenalidomide complex reveals basis for responsiveness to thalidomide analogsLenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cellsThe myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins
Ce produit répond aux critères suivants pour être admissible aux récompenses suivantes :